CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Dipexium Pharmaceuticals, Inc.  (DPRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Dipexium Pharmaceuticals's Quick Ratio

DPRX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

DPRX Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Current Liabilities Change -46.83 % 32.1 % 10.51 % -19.14 % 24.57 %
Y / Y Cash & cash equivalent Change -54.23 % -48.14 % -47.85 % -44.45 % 13.29 %
Quick Ratio MRQ 26.98 7.89 21.21 23.93 31.35
Overall Ranking # 103 # 100 # 99 # 0 # 0
Seq. Current Liabilities Change -78.22 % 138.28 % -5.81 % 8.77 % -45.89 %
Seq. Cash & cash equivalent Change -25.47 % -11.43 % -16.51 % -16.95 % -15.55 %



Quick Ratio first quarter 2017 Comment
Current Liabilities decreased faster than Dipexium Pharmaceuticals's Cash & cash equivalent, this led to improvement in Dipexium Pharmaceuticals's Quick Ratio to 26.98, Quick Ratio remained below Dipexium Pharmaceuticals, Inc. average.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Quick Ratio than Dipexium Pharmaceuticals in first quarter 2017. While Quick Ratio total ranking has improved so far to 103, from total ranking in previous quarter at 341.

Explain Quick Ratio?
What are DPRX Segments?
See Quick Ratio DPRX on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 15
Overall Market # 103


Quick Ratio Statistics
High Average Low
52.43 30.13 7.89
(Mar 31 2014)   (Dec 31 2016)


You need to upgrade your Flash Player


Financial Statements
Dipexium Pharmaceuticals's Current Liabilities $ 0 Millions Visit DPRX's Balance sheet
Dipexium Pharmaceuticals's Cash & cash equivalent $ 12 Millions Visit DPRX's Balance sheet
Source of DPRX's Sales Visit DPRX's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Flex Pharma, Inc.  58.23 $ 52.815  Millions$ 0.907  Millions
Corvus Pharmaceuticals, Inc.  50.42 $ 122.064  Millions$ 2.421  Millions
Prothena Corp Plc  42.32 $ 506.550  Millions$ 11.970  Millions
Abeona Therapeutics Inc.  30.61 $ 63.212  Millions$ 2.065  Millions
Syros Pharmaceuticals, Inc.  27.67 $ 70.494  Millions$ 2.548  Millions
Dipexium Pharmaceuticals, Inc.  26.98 $ 12.471  Millions$ 0.462  Millions
Endocyte Inc  25.95 $ 127.562  Millions$ 4.915  Millions
Aimmune Therapeutics, Inc.  24.09 $ 246.247  Millions$ 10.223  Millions
Sierra Oncology, Inc.  23.94 $ 125.025  Millions$ 5.222  Millions
Loxo Oncology, Inc.  23.09 $ 240.315  Millions$ 10.408  Millions
Kindred Biosciences, Inc.  22.88 $ 65.138  Millions$ 2.847  Millions
Sophiris Bio Inc.  22.84 $ 25.694  Millions$ 1.125  Millions
Intra-cellular Therapies, Inc.  22.54 $ 367.781  Millions$ 16.319  Millions
Inotek Pharmaceuticals Corporation  21.77 $ 114.705  Millions$ 5.268  Millions
Medicinova Inc  21.17 $ 21.637  Millions$ 1.022  Millions
Aquinox Pharmaceuticals, Inc  20.88 $ 121.581  Millions$ 5.824  Millions
Ra Pharmaceuticals, Inc.  19.86 $ 105.373  Millions$ 5.307  Millions
Pain Therapeutics Inc  19.55 $ 17.264  Millions$ 0.883  Millions
Dermira, Inc.  19.46 $ 414.627  Millions$ 21.311  Millions
Enanta Pharmaceuticals Inc  19.18 $ 175.573  Millions$ 9.154  Millions
Catalyst Pharmaceuticals, Inc.  19.17 $ 36.527  Millions$ 1.906  Millions
Chimerix Inc  18.73 $ 161.695  Millions$ 8.632  Millions
Biospecifics Technologies Corp  18.39 $ 47.872  Millions$ 2.603  Millions
Otonomy, Inc.  17.90 $ 168.124  Millions$ 9.390  Millions
Global Blood Therapeutics, Inc.  16.57 $ 244.324  Millions$ 14.747  Millions
Scynexis Inc  16.35 $ 54.899  Millions$ 3.358  Millions
Xenon Pharmaceuticals Inc.  16.16 $ 58.027  Millions$ 3.591  Millions
Kura Oncology, Inc.  16.04 $ 59.153  Millions$ 3.688  Millions
Aduro Biotech, Inc.  14.76 $ 353.961  Millions$ 23.975  Millions
Aeglea Biotherapeutics, Inc.  14.62 $ 57.868  Millions$ 3.957  Millions
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HDS's Profile

Stock Price

HDS's Financials

HDS's Expectations

Business Description

Fundamentals

Charts & Quotes

HDS's News

Suppliers

HDS's Competitors

Customers & Markets

Economic Indicators

HDS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com